About

About Us

Located in Cambridge, Massachusetts, Abazyme was created out of the understanding that one of the keys to successful life science research is the availability of excellent reagents and tools. Our clients range from small start-ups to major pharmaceutical companies. They all look to partner with Abazyme because of our proven technical track record and our willingness to serve as true research partners.

We are researchers, so we "get" researchers. We've walked in their shoes and we understand that success comes from the performance of every step along the way. From synthetic biology, target validation, diagnostic and therapeutic development, we aspire to provide services and products that solve problems.

Abazyme is at the Intersection of Immunology and Molecular Biology

We have the expertise to design and implement of antibody-based strategies for our clients.  Common shortcomings of monoclonal antibodies for research are: supply can be fragile and you can’t engineer them to suit your purpose (what you get, is what you get). We’ve solved that by providing a recombinant solution to antibody development: ACE ™ antibody cloning technology. Developed by our scientists, ACE ™ enables us to clone monoclonal antibodies into stable expression vectors. Not only do these vectors offer permanent supply, but they can be modified to fit the needs of an unlimited array of use.

Along Came SLiCE™

As part of our ACE ™ antibody cloning efforts, we needed to efficiently create expression plasmids from multiple fragments of DNA. Out of that need, we licensed SLiCE™, a new cloning reagent that gives us the best multi-fragment cloning we've seen. We've decided to launch it as a product because it will help so many molecular biologists looking for better cloning efficiencies. We've added SLiCE™ to our catalog of great reagents and ELISA kits.

Our company goals are clear: provide the best research services and products to life science researchers so that they can succeed.